Bevacizumab Treatment for Metastatic Colorectal Cancer in Real-World Clinical Practice

Background and Objectives: Colorectal cancer (CRC) is a leading cause of cancer-related mortality and morbidity worldwide. Bevacizumab was approved for the treatment of metastatic colorectal cancer (mCRC) based on favorable benefit-risk assessments from randomized controlled trials, but evidence on...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinu, Ioana Mihaela, Mihăilă, Mariana, Diculescu, Mircea Mihai, Croitoru, Vlad Mihai, Turcu-Stiolica, Adina, Bogdan, Diana, Miron, Monica Ionela, Lungulescu, Cristian Virgil, Alexandrescu, Sorin Tiberiu, Dumitrașcu, Traian, Buică, Florina, Luca, Ioana Niculina, Lungulescu, Cristina, Negulescu, Madalina Cristina, Gramaticu, Iulia Magdalena, Cazacu, Irina Mihaela, Croitoru, Adina Emilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963555/
https://www.ncbi.nlm.nih.gov/pubmed/36837551
http://dx.doi.org/10.3390/medicina59020350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963555/
https://www.ncbi.nlm.nih.gov/pubmed/36837551
http://dx.doi.org/10.3390/medicina59020350

Ejemplares similares